Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2018-08-01
2019-09-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Methods: This experimental-type study was conducted in the operating room of the Department of General Surgery of a University Hospital. In the study, the surgeries were completed with standard practice and four different protective measures that could affect surgical smoke exposure. Blood and urine samples were collected from the surgical team before and after the surgery. Consequently, 70 blood and 70 urine samples were collected. The Wilcoxon signed-rank test was used to compare pre- and post-operative analyses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Surgical Smoke on Air Quality
NCT04856995
Reducing the Negative Effects of Surgical Conditions Use of Double Layer Mask Against Electrocautery With Smoke Filter
NCT06550492
The Effect of Masks on Surgical Smoke Exposure
NCT07161609
Nitrous Oxide Frequency of Use and Causes in Hospital in Turkey
NCT04124562
Smoking Cessation, Anxiety, Pain Relationship
NCT04405219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2.3 Collection of Study Data 2.3.1 Data Collection Tools The Surgery Data Collection Form, which was created by the researchers in line with the relevant literature (Romano et al. 2016, 2017, Ragde et al. 2014; Tseng et al. 2014, Lin et al. 2010, Hollmann et al. 2004) to evaluate the information about the surgery, was used to collect the data. Other data collection tools were the N95 and safety equipment, the RapidVac™ Smoke Evacuator system for smoke evacuation, as well as the pencil type (smoke extractor) and smoke tubing evacuators.
2.3.2 Data Collection Method Blood and urine samples of the surgical team were collected before the total mastectomy in five different situations listed below that may affect surgical smoke exposure.
After the surgery is completed with routine applications (without taking any measures for smoke evacuation), After completing the surgery with the use of special safety equipment (N95 mask, safety glasses and without any measures for smoke evacuation), After the evacuation of the smoke caused by the surgery with a wall-mounted aspirator, After the evacuation of the smoke caused by the surgery with a smoke tubing and After the evacuation of the smoke caused by the surgery with a smoke evacuation pencil.
The blood samples were kept in a transport bag that maintained the temperature range between 2 and 4 °C until they reached the laboratory and kept at -20 °C for analysis. Blood samples were evaluated in the laboratory for benzene, toluene, xylene and styrene.
Similarly, the urine samples were kept in a transport bag that maintained the temperature range between 2 and 4 °C until they reached the laboratory and kept at -20 °C for analysis. The urine samples were evaluated in terms of urinary metabolites benzene-phenol-TT muconic acid, toluene-hippuric acid-O, cresol, xylene-hippuric acid and phenol-phenol in the laboratory.
Blood and urine analysis in the study was performed by the Central Research Test and Analysis Laboratory Application and Research Center of the university of this study.
2.3.3 Evaluation and Analysis of Data The study data was evaluated using the IBM SPSS Statistics 25.0 Statistics program. The Wilcoxon signed-rank test was used to compare pre- and post-operative analyses. Moreover, 0.05 was accepted as significant.
Gas chromatography/mass spectrometry was used for the analysis of blood and urine samples of the surgical team.
2.4 Ethical Aspect of Study Permission (11.01.2018-E.11195) was obtained from the Clinical Research Ethics Committee of the university of this study. Also, written permission (29.01.2018-E27595) from the institution where the research was conducted as well as informed written consent from the participants in the study were obtained.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SMOKE PROTECTION
Pre- and post-operative blood and urine samples of the surgical team (surgeon, surgical resident, anaesthesiologist, scrub nurse, circulating nurse, support staff and researcher), who worked in the standard practice, and the use of four different preventive measures that may affect the surgical smoke exposure during total mastectomy surgery in the operating room of the General Surgery Department of a University HospitaL. The surgical resident, anaesthesiologist, anaesthesia technician and support staff included in the study did not consist of the same people due to the change in the work schedules. Blood and urine samples were collected from a team of seven people before and after surgery \[7 volunteers × 2 (blood and urine before and after surgery) = 14 (14 blood analysis + 14 urine analysis) 14 × 5 surgery = 70 (70 blood analysis + 70 urine analysis)\].
surgical smoke affects
The study, experimental type, was conducted to investigate the effects of five different methods on surgical smoke protection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
surgical smoke affects
The study, experimental type, was conducted to investigate the effects of five different methods on surgical smoke protection.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agree to participate in the study,
Exclusion Criteria
* Not wanting to give blood or urine sample
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Burcak Sahin Koze
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Burcak Sahin Koze, Mscn
Role: PRINCIPAL_INVESTIGATOR
Ege University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University
Izmir, Bornova, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Experimental
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.